📰 Amit Sachdev News
Page 2 - Amit Sachdev News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Amit Sachdev. Real-time updates on events, politics, business and more.
April 28, 2024
Intact Investment Management Inc. lowered its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 24.0% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,900 shares of the pharmaceutical company’s stock after selling 600 shares during the […]
April 28, 2024
Intact Investment Management Inc. lowered its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 24.0% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,900 shares of the pharmaceutical company’s stock after selling 600 shares during the period. Intact Investment Management Inc.’s holdings […]
April 27, 2024
Callan Capital LLC increased its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 281.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 4,191 shares of the pharmaceutical company’s stock after purchasing an additional 3,091 shares during the […]
April 25, 2024
Tokio Marine Asset Management Co. Ltd. boosted its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 9.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 6,526 shares of the pharmaceutical company’s stock after acquiring an additional 564 shares […]
April 25, 2024
Syon Capital LLC increased its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 5.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,276 shares of the pharmaceutical company’s stock after purchasing an additional 111 shares […]
April 25, 2024
Syon Capital LLC lifted its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 5.1% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 2,276 shares of the pharmaceutical company’s stock after purchasing an additional 111 shares during the period. Syon Capital LLC’s […]
April 25, 2024
Syon Capital LLC increased its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 5.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,276 shares of the pharmaceutical company’s stock after purchasing an additional 111 shares […]
April 23, 2024
Illinois Municipal Retirement Fund boosted its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 3.6% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 86,720 shares of the pharmaceutical company’s stock after buying an additional 3,033 shares during the quarter. Vertex Pharmaceuticals accounts for 0.6% of Illinois Municipal Retirement Fund’s holdings, making […]
April 23, 2024
StockNews.com lowered shares of Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) from a strong-buy rating to a buy rating in a report released on Saturday morning. VRTX has been the subject of several other research reports. Wells Fargo & Company boosted their target price on shares of Vertex Pharmaceuticals from $500.00 to $540.00 and gave the […]
April 23, 2024
Illinois Municipal Retirement Fund raised its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 3.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 86,720 shares of the pharmaceutical company’s stock after buying an additional 3,033 shares during the period. Vertex Pharmaceuticals comprises […]